Streetbeat News

Price Targets

AMTB

Raymond James analyst Michael Rose has maintained an Outperform rating on Amerant Bancorp (NYSE:AMTB) but lowered the price target from $24 to $23.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 4:03 pm

MTZ

Citigroup analyst Andrew Kaplowitz has maintained a 'Buy' rating on MasTec (NYSE:MTZ), but lowered the price target from $116 to $91.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:55 pm

ACM

Citigroup analyst Andrew Kaplowitz maintains a Buy rating on AECOM (NYSE:ACM) but lowers the price target from $105 to $93.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:54 pm

FLR

Citigroup analyst Andrew Kaplowitz maintains a Neutral rating on Fluor (NYSE:FLR) and raises the price target from $40 to $41.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:51 pm

KBR

Citigroup analyst Andrew Kaplowitz maintains a Buy rating on KBR (NYSE:KBR) but lowers the price target from $75 to $74.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:49 pm

WAL

RBC Capital analyst Jon Arfstrom has maintained an 'Outperform' rating on Western Alliance (NYSE:WAL), but lowered the price target from $56 to $54.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:49 pm

RF

RBC Capital analyst Gerard Cassidy has maintained an 'Outperform' rating on Regions Financial Corp (NYSE:RF) but lowered the price target from $23 to $19.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:47 pm

TSX:AC

Citigroup analyst Stephen Trent has maintained a 'Buy' rating on Air Canada, but has lowered the price target from C$31 to C$28.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:45 pm

MNMD

RBC Capital analyst Brian Abrahams has reiterated his 'Outperform' rating on Mind Medicine (NASDAQ:MNMD) and maintained a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:45 pm

HBAN

RBC Capital analyst Jon Arfstrom has maintained an 'Outperform' rating on Huntington Bancshares (NASDAQ:HBAN), but lowered the price target from $13 to $12.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:43 pm